カテゴリ： 世界, 医療/バイオ, QYResearch

チロシンプロテインキナーゼマーの世界市場2023年：プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1

■ 英語タイトル：Global Tyrosine Protein Kinase Mer Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8915）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8915
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[チロシンプロテインキナーゼマーの世界市場2023年：プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はチロシンプロテインキナーゼマーのグローバル市場について調査・分析し、世界のチロシンプロテインキナーゼマー市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1）、用途別セグメント分析（腫瘍学、眼科）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Celldex Therapeutics Inc、Celon Pharma SA、Dong-A Socio Holdings Co Ltd、Eli Lilly and Co、F. Hoffmann-La Roche Ltd、HEC Pharma Co Ltd、Hope Biosciences Inc、Incyte Corp、Mediolanum farmaceutici SpA、Meryx Inc、Mirati Therapeutics Inc、Ono Pharmaceutical Co Ltd、Pfizer Inc、Qurient Co Ltd、Rgenix Inc、SignalChem Lifesciences Corpなどが含まれています。チロシンプロテインキナーゼマーのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、チロシンプロテインキナーゼマー市場規模を算出する際に考慮しました。

・チロシンプロテインキナーゼマー市場の概要
- 製品の定義
- チロシンプロテインキナーゼマーの種類別セグメント
- 世界のチロシンプロテインキナーゼマー市場規模：タイプ別分析（プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1）
- チロシンプロテインキナーゼマーの用途別セグメント
- 世界のチロシンプロテインキナーゼマー市場規模：用途別分析（腫瘍学、眼科）
- 世界のチロシンプロテインキナーゼマー市場規模予測（2018年-2029年）
- チロシンプロテインキナーゼマーの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- チロシンプロテインキナーゼマー市場の競争状況およびトレンド

・チロシンプロテインキナーゼマーの地域別市場規模
- 北米のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- 米国のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- ヨーロッパのチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- アジア太平洋のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- 中国のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- 日本のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- 韓国のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- インドのチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- オーストラリアのチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- 中南米のチロシンプロテインキナーゼマー市場規模（2018年-2029年）
- 中東・アフリカのチロシンプロテインキナーゼマー市場規模（2018年-2029年）

・種類別セグメント：プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1
- 世界のチロシンプロテインキナーゼマーのタイプ別販売量（2018年-2023年）
- 世界のチロシンプロテインキナーゼマーのタイプ別売上（2018年-2023年）
- 世界のチロシンプロテインキナーゼマーのタイプ別価格

・用途別セグメント：腫瘍学、眼科
- 世界のチロシンプロテインキナーゼマーの用途別販売量（2018年-2023年）
- 世界のチロシンプロテインキナーゼマーの用途別売上（2018年-2023年）
- 世界のチロシンプロテインキナーゼマーの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Celldex Therapeutics Inc、Celon Pharma SA、Dong-A Socio Holdings Co Ltd、Eli Lilly and Co、F. Hoffmann-La Roche Ltd、HEC Pharma Co Ltd、Hope Biosciences Inc、Incyte Corp、Mediolanum farmaceutici SpA、Meryx Inc、Mirati Therapeutics Inc、Ono Pharmaceutical Co Ltd、Pfizer Inc、Qurient Co Ltd、Rgenix Inc、SignalChem Lifesciences Corp

・産業チェーンと販売チャネルの分析
- チロシンプロテインキナーゼマー産業チェーン分析
- チロシンプロテインキナーゼマーの主要原材料
- チロシンプロテインキナーゼマーの販売チャネル
- チロシンプロテインキナーゼマーのディストリビューター
- チロシンプロテインキナーゼマーの主要顧客

・チロシンプロテインキナーゼマー市場ダイナミクス
- チロシンプロテインキナーゼマーの業界動向
- チロシンプロテインキナーゼマー市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) – Proto-oncogene tyrosine-protein kinase MER is an enzyme encoded by the MERTK gene.It regulates many physiological processes including cell survival, migration, differentiation,and phagocytosis of apoptotic cells.It plays a role in various processes such as macrophage clearance of apoptotic cells,platelet aggregation,cytoskeleton reorganization and engulfment.Functions in the retinal pigment epithelium (RPE) as a regulator of rod outer segments fragments phagocytosis.It also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1.
Highlights
The global Tyrosine Protein Kinase Mer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Tyrosine Protein Kinase Mer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tyrosine Protein Kinase Mer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Tyrosine Protein Kinase Mer include Celldex Therapeutics Inc, Celon Pharma SA, Dong-A Socio Holdings Co Ltd, Eli Lilly and Co, F. Hoffmann-La Roche Ltd, HEC Pharma Co Ltd, Hope Biosciences Inc, Incyte Corp and Mediolanum farmaceutici SpA, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tyrosine Protein Kinase Mer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tyrosine Protein Kinase Mer.
The Tyrosine Protein Kinase Mer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tyrosine Protein Kinase Mer market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tyrosine Protein Kinase Mer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Celldex Therapeutics Inc
Celon Pharma SA
Dong-A Socio Holdings Co Ltd
Eli Lilly and Co
F. Hoffmann-La Roche Ltd
HEC Pharma Co Ltd
Hope Biosciences Inc
Incyte Corp
Mediolanum farmaceutici SpA
Meryx Inc
Mirati Therapeutics Inc
Ono Pharmaceutical Co Ltd
Pfizer Inc
Qurient Co Ltd
Rgenix Inc
SignalChem Lifesciences Corp
Segment by Type
Proto Oncogene c Mer
Receptor Tyrosine Kinase MerTK
MERTK
EC 2.7.10.1
Segment by Application
Oncology
Ophthalmology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tyrosine Protein Kinase Mer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tyrosine Protein Kinase Mer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Tyrosine Protein Kinase Mer Market Overview
1.1 Product Overview and Scope of Tyrosine Protein Kinase Mer
1.2 Tyrosine Protein Kinase Mer Segment by Type
1.2.1 Global Tyrosine Protein Kinase Mer Market Value Comparison by Type (2023-2029)
1.2.2 Proto Oncogene c Mer
1.2.3 Receptor Tyrosine Kinase MerTK
1.2.4 MERTK
1.2.5 EC 2.7.10.1
1.3 Tyrosine Protein Kinase Mer Segment by Application
1.3.1 Global Tyrosine Protein Kinase Mer Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Ophthalmology
1.4 Global Tyrosine Protein Kinase Mer Market Size Estimates and Forecasts
1.4.1 Global Tyrosine Protein Kinase Mer Revenue 2018-2029
1.4.2 Global Tyrosine Protein Kinase Mer Sales 2018-2029
1.4.3 Global Tyrosine Protein Kinase Mer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tyrosine Protein Kinase Mer Market Competition by Manufacturers
2.1 Global Tyrosine Protein Kinase Mer Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tyrosine Protein Kinase Mer Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tyrosine Protein Kinase Mer Average Price by Manufacturers (2018-2023)
2.4 Global Tyrosine Protein Kinase Mer Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tyrosine Protein Kinase Mer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tyrosine Protein Kinase Mer, Product Type & Application
2.7 Tyrosine Protein Kinase Mer Market Competitive Situation and Trends
2.7.1 Tyrosine Protein Kinase Mer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tyrosine Protein Kinase Mer Players Market Share by Revenue
2.7.3 Global Tyrosine Protein Kinase Mer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tyrosine Protein Kinase Mer Retrospective Market Scenario by Region
3.1 Global Tyrosine Protein Kinase Mer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tyrosine Protein Kinase Mer Global Tyrosine Protein Kinase Mer Sales by Region: 2018-2029
3.2.1 Global Tyrosine Protein Kinase Mer Sales by Region: 2018-2023
3.2.2 Global Tyrosine Protein Kinase Mer Sales by Region: 2024-2029
3.3 Global Tyrosine Protein Kinase Mer Global Tyrosine Protein Kinase Mer Revenue by Region: 2018-2029
3.3.1 Global Tyrosine Protein Kinase Mer Revenue by Region: 2018-2023
3.3.2 Global Tyrosine Protein Kinase Mer Revenue by Region: 2024-2029
3.4 North America Tyrosine Protein Kinase Mer Market Facts & Figures by Country
3.4.1 North America Tyrosine Protein Kinase Mer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tyrosine Protein Kinase Mer Sales by Country (2018-2029)
3.4.3 North America Tyrosine Protein Kinase Mer Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tyrosine Protein Kinase Mer Market Facts & Figures by Country
3.5.1 Europe Tyrosine Protein Kinase Mer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tyrosine Protein Kinase Mer Sales by Country (2018-2029)
3.5.3 Europe Tyrosine Protein Kinase Mer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tyrosine Protein Kinase Mer Market Facts & Figures by Country
3.6.1 Asia Pacific Tyrosine Protein Kinase Mer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tyrosine Protein Kinase Mer Sales by Country (2018-2029)
3.6.3 Asia Pacific Tyrosine Protein Kinase Mer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tyrosine Protein Kinase Mer Market Facts & Figures by Country
3.7.1 Latin America Tyrosine Protein Kinase Mer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tyrosine Protein Kinase Mer Sales by Country (2018-2029)
3.7.3 Latin America Tyrosine Protein Kinase Mer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tyrosine Protein Kinase Mer Market Facts & Figures by Country
3.8.1 Middle East and Africa Tyrosine Protein Kinase Mer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tyrosine Protein Kinase Mer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tyrosine Protein Kinase Mer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tyrosine Protein Kinase Mer Sales by Type (2018-2029)
4.1.1 Global Tyrosine Protein Kinase Mer Sales by Type (2018-2023)
4.1.2 Global Tyrosine Protein Kinase Mer Sales by Type (2024-2029)
4.1.3 Global Tyrosine Protein Kinase Mer Sales Market Share by Type (2018-2029)
4.2 Global Tyrosine Protein Kinase Mer Revenue by Type (2018-2029)
4.2.1 Global Tyrosine Protein Kinase Mer Revenue by Type (2018-2023)
4.2.2 Global Tyrosine Protein Kinase Mer Revenue by Type (2024-2029)
4.2.3 Global Tyrosine Protein Kinase Mer Revenue Market Share by Type (2018-2029)
4.3 Global Tyrosine Protein Kinase Mer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tyrosine Protein Kinase Mer Sales by Application (2018-2029)
5.1.1 Global Tyrosine Protein Kinase Mer Sales by Application (2018-2023)
5.1.2 Global Tyrosine Protein Kinase Mer Sales by Application (2024-2029)
5.1.3 Global Tyrosine Protein Kinase Mer Sales Market Share by Application (2018-2029)
5.2 Global Tyrosine Protein Kinase Mer Revenue by Application (2018-2029)
5.2.1 Global Tyrosine Protein Kinase Mer Revenue by Application (2018-2023)
5.2.2 Global Tyrosine Protein Kinase Mer Revenue by Application (2024-2029)
5.2.3 Global Tyrosine Protein Kinase Mer Revenue Market Share by Application (2018-2029)
5.3 Global Tyrosine Protein Kinase Mer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Celldex Therapeutics Inc
6.1.1 Celldex Therapeutics Inc Corporation Information
6.1.2 Celldex Therapeutics Inc Description and Business Overview
6.1.3 Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Product Portfolio
6.1.5 Celldex Therapeutics Inc Recent Developments/Updates
6.2 Celon Pharma SA
6.2.1 Celon Pharma SA Corporation Information
6.2.2 Celon Pharma SA Description and Business Overview
6.2.3 Celon Pharma SA Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Celon Pharma SA Tyrosine Protein Kinase Mer Product Portfolio
6.2.5 Celon Pharma SA Recent Developments/Updates
6.3 Dong-A Socio Holdings Co Ltd
6.3.1 Dong-A Socio Holdings Co Ltd Corporation Information
6.3.2 Dong-A Socio Holdings Co Ltd Description and Business Overview
6.3.3 Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Product Portfolio
6.3.5 Dong-A Socio Holdings Co Ltd Recent Developments/Updates
6.4 Eli Lilly and Co
6.4.1 Eli Lilly and Co Corporation Information
6.4.2 Eli Lilly and Co Description and Business Overview
6.4.3 Eli Lilly and Co Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly and Co Tyrosine Protein Kinase Mer Product Portfolio
6.4.5 Eli Lilly and Co Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd
6.5.1 F. Hoffmann-La Roche Ltd Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.5.4 F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
6.6 HEC Pharma Co Ltd
6.6.1 HEC Pharma Co Ltd Corporation Information
6.6.2 HEC Pharma Co Ltd Description and Business Overview
6.6.3 HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Product Portfolio
6.6.5 HEC Pharma Co Ltd Recent Developments/Updates
6.7 Hope Biosciences Inc
6.6.1 Hope Biosciences Inc Corporation Information
6.6.2 Hope Biosciences Inc Description and Business Overview
6.6.3 Hope Biosciences Inc Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hope Biosciences Inc Tyrosine Protein Kinase Mer Product Portfolio
6.7.5 Hope Biosciences Inc Recent Developments/Updates
6.8 Incyte Corp
6.8.1 Incyte Corp Corporation Information
6.8.2 Incyte Corp Description and Business Overview
6.8.3 Incyte Corp Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Incyte Corp Tyrosine Protein Kinase Mer Product Portfolio
6.8.5 Incyte Corp Recent Developments/Updates
6.9 Mediolanum farmaceutici SpA
6.9.1 Mediolanum farmaceutici SpA Corporation Information
6.9.2 Mediolanum farmaceutici SpA Description and Business Overview
6.9.3 Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Product Portfolio
6.9.5 Mediolanum farmaceutici SpA Recent Developments/Updates
6.10 Meryx Inc
6.10.1 Meryx Inc Corporation Information
6.10.2 Meryx Inc Description and Business Overview
6.10.3 Meryx Inc Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Meryx Inc Tyrosine Protein Kinase Mer Product Portfolio
6.10.5 Meryx Inc Recent Developments/Updates
6.11 Mirati Therapeutics Inc
6.11.1 Mirati Therapeutics Inc Corporation Information
6.11.2 Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Description and Business Overview
6.11.3 Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Product Portfolio
6.11.5 Mirati Therapeutics Inc Recent Developments/Updates
6.12 Ono Pharmaceutical Co Ltd
6.12.1 Ono Pharmaceutical Co Ltd Corporation Information
6.12.2 Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Description and Business Overview
6.12.3 Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Product Portfolio
6.12.5 Ono Pharmaceutical Co Ltd Recent Developments/Updates
6.13 Pfizer Inc
6.13.1 Pfizer Inc Corporation Information
6.13.2 Pfizer Inc Tyrosine Protein Kinase Mer Description and Business Overview
6.13.3 Pfizer Inc Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Pfizer Inc Tyrosine Protein Kinase Mer Product Portfolio
6.13.5 Pfizer Inc Recent Developments/Updates
6.14 Qurient Co Ltd
6.14.1 Qurient Co Ltd Corporation Information
6.14.2 Qurient Co Ltd Tyrosine Protein Kinase Mer Description and Business Overview
6.14.3 Qurient Co Ltd Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Qurient Co Ltd Tyrosine Protein Kinase Mer Product Portfolio
6.14.5 Qurient Co Ltd Recent Developments/Updates
6.15 Rgenix Inc
6.15.1 Rgenix Inc Corporation Information
6.15.2 Rgenix Inc Tyrosine Protein Kinase Mer Description and Business Overview
6.15.3 Rgenix Inc Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Rgenix Inc Tyrosine Protein Kinase Mer Product Portfolio
6.15.5 Rgenix Inc Recent Developments/Updates
6.16 SignalChem Lifesciences Corp
6.16.1 SignalChem Lifesciences Corp Corporation Information
6.16.2 SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Description and Business Overview
6.16.3 SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Sales, Revenue and Gross Margin (2018-2023)
6.16.4 SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Product Portfolio
6.16.5 SignalChem Lifesciences Corp Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tyrosine Protein Kinase Mer Industry Chain Analysis
7.2 Tyrosine Protein Kinase Mer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tyrosine Protein Kinase Mer Production Mode & Process
7.4 Tyrosine Protein Kinase Mer Sales and Marketing
7.4.1 Tyrosine Protein Kinase Mer Sales Channels
7.4.2 Tyrosine Protein Kinase Mer Distributors
7.5 Tyrosine Protein Kinase Mer Customers
8 Tyrosine Protein Kinase Mer Market Dynamics
8.1 Tyrosine Protein Kinase Mer Industry Trends
8.2 Tyrosine Protein Kinase Mer Market Drivers
8.3 Tyrosine Protein Kinase Mer Market Challenges
8.4 Tyrosine Protein Kinase Mer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Tyrosine Protein Kinase Mer Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Tyrosine Protein Kinase Mer Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Tyrosine Protein Kinase Mer Market Competitive Situation by Manufacturers in 2022
Table 4. Global Tyrosine Protein Kinase Mer Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Tyrosine Protein Kinase Mer Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Tyrosine Protein Kinase Mer Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Tyrosine Protein Kinase Mer Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Tyrosine Protein Kinase Mer Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Tyrosine Protein Kinase Mer, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Tyrosine Protein Kinase Mer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tyrosine Protein Kinase Mer, Product Type & Application
Table 12. Global Key Manufacturers of Tyrosine Protein Kinase Mer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tyrosine Protein Kinase Mer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tyrosine Protein Kinase Mer as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tyrosine Protein Kinase Mer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Tyrosine Protein Kinase Mer Sales by Region (2018-2023) & (K Units)
Table 18. Global Tyrosine Protein Kinase Mer Sales Market Share by Region (2018-2023)
Table 19. Global Tyrosine Protein Kinase Mer Sales by Region (2024-2029) & (K Units)
Table 20. Global Tyrosine Protein Kinase Mer Sales Market Share by Region (2024-2029)
Table 21. Global Tyrosine Protein Kinase Mer Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Tyrosine Protein Kinase Mer Revenue Market Share by Region (2018-2023)
Table 23. Global Tyrosine Protein Kinase Mer Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Tyrosine Protein Kinase Mer Revenue Market Share by Region (2024-2029)
Table 25. North America Tyrosine Protein Kinase Mer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Tyrosine Protein Kinase Mer Sales by Country (2018-2023) & (K Units)
Table 27. North America Tyrosine Protein Kinase Mer Sales by Country (2024-2029) & (K Units)
Table 28. North America Tyrosine Protein Kinase Mer Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Tyrosine Protein Kinase Mer Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Tyrosine Protein Kinase Mer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Tyrosine Protein Kinase Mer Sales by Country (2018-2023) & (K Units)
Table 32. Europe Tyrosine Protein Kinase Mer Sales by Country (2024-2029) & (K Units)
Table 33. Europe Tyrosine Protein Kinase Mer Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Tyrosine Protein Kinase Mer Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Tyrosine Protein Kinase Mer Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Tyrosine Protein Kinase Mer Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Tyrosine Protein Kinase Mer Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Tyrosine Protein Kinase Mer Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Tyrosine Protein Kinase Mer Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Tyrosine Protein Kinase Mer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Tyrosine Protein Kinase Mer Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Tyrosine Protein Kinase Mer Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Tyrosine Protein Kinase Mer Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Tyrosine Protein Kinase Mer Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Tyrosine Protein Kinase Mer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Tyrosine Protein Kinase Mer Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Tyrosine Protein Kinase Mer Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Tyrosine Protein Kinase Mer Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Tyrosine Protein Kinase Mer Sales (K Units) by Type (2018-2023)
Table 51. Global Tyrosine Protein Kinase Mer Sales (K Units) by Type (2024-2029)
Table 52. Global Tyrosine Protein Kinase Mer Sales Market Share by Type (2018-2023)
Table 53. Global Tyrosine Protein Kinase Mer Sales Market Share by Type (2024-2029)
Table 54. Global Tyrosine Protein Kinase Mer Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Tyrosine Protein Kinase Mer Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Tyrosine Protein Kinase Mer Revenue Market Share by Type (2018-2023)
Table 57. Global Tyrosine Protein Kinase Mer Revenue Market Share by Type (2024-2029)
Table 58. Global Tyrosine Protein Kinase Mer Price (US$/Unit) by Type (2018-2023)
Table 59. Global Tyrosine Protein Kinase Mer Price (US$/Unit) by Type (2024-2029)
Table 60. Global Tyrosine Protein Kinase Mer Sales (K Units) by Application (2018-2023)
Table 61. Global Tyrosine Protein Kinase Mer Sales (K Units) by Application (2024-2029)
Table 62. Global Tyrosine Protein Kinase Mer Sales Market Share by Application (2018-2023)
Table 63. Global Tyrosine Protein Kinase Mer Sales Market Share by Application (2024-2029)
Table 64. Global Tyrosine Protein Kinase Mer Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Tyrosine Protein Kinase Mer Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Tyrosine Protein Kinase Mer Revenue Market Share by Application (2018-2023)
Table 67. Global Tyrosine Protein Kinase Mer Revenue Market Share by Application (2024-2029)
Table 68. Global Tyrosine Protein Kinase Mer Price (US$/Unit) by Application (2018-2023)
Table 69. Global Tyrosine Protein Kinase Mer Price (US$/Unit) by Application (2024-2029)
Table 70. Celldex Therapeutics Inc Corporation Information
Table 71. Celldex Therapeutics Inc Description and Business Overview
Table 72. Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Celldex Therapeutics Inc Tyrosine Protein Kinase Mer Product
Table 74. Celldex Therapeutics Inc Recent Developments/Updates
Table 75. Celon Pharma SA Corporation Information
Table 76. Celon Pharma SA Description and Business Overview
Table 77. Celon Pharma SA Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Celon Pharma SA Tyrosine Protein Kinase Mer Product
Table 79. Celon Pharma SA Recent Developments/Updates
Table 80. Dong-A Socio Holdings Co Ltd Corporation Information
Table 81. Dong-A Socio Holdings Co Ltd Description and Business Overview
Table 82. Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Dong-A Socio Holdings Co Ltd Tyrosine Protein Kinase Mer Product
Table 84. Dong-A Socio Holdings Co Ltd Recent Developments/Updates
Table 85. Eli Lilly and Co Corporation Information
Table 86. Eli Lilly and Co Description and Business Overview
Table 87. Eli Lilly and Co Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Eli Lilly and Co Tyrosine Protein Kinase Mer Product
Table 89. Eli Lilly and Co Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd Corporation Information
Table 91. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. F. Hoffmann-La Roche Ltd Tyrosine Protein Kinase Mer Product
Table 94. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 95. HEC Pharma Co Ltd Corporation Information
Table 96. HEC Pharma Co Ltd Description and Business Overview
Table 97. HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. HEC Pharma Co Ltd Tyrosine Protein Kinase Mer Product
Table 99. HEC Pharma Co Ltd Recent Developments/Updates
Table 100. Hope Biosciences Inc Corporation Information
Table 101. Hope Biosciences Inc Description and Business Overview
Table 102. Hope Biosciences Inc Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hope Biosciences Inc Tyrosine Protein Kinase Mer Product
Table 104. Hope Biosciences Inc Recent Developments/Updates
Table 105. Incyte Corp Corporation Information
Table 106. Incyte Corp Description and Business Overview
Table 107. Incyte Corp Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Incyte Corp Tyrosine Protein Kinase Mer Product
Table 109. Incyte Corp Recent Developments/Updates
Table 110. Mediolanum farmaceutici SpA Corporation Information
Table 111. Mediolanum farmaceutici SpA Description and Business Overview
Table 112. Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Mediolanum farmaceutici SpA Tyrosine Protein Kinase Mer Product
Table 114. Mediolanum farmaceutici SpA Recent Developments/Updates
Table 115. Meryx Inc Corporation Information
Table 116. Meryx Inc Description and Business Overview
Table 117. Meryx Inc Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Meryx Inc Tyrosine Protein Kinase Mer Product
Table 119. Meryx Inc Recent Developments/Updates
Table 120. Mirati Therapeutics Inc Corporation Information
Table 121. Mirati Therapeutics Inc Description and Business Overview
Table 122. Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Mirati Therapeutics Inc Tyrosine Protein Kinase Mer Product
Table 124. Mirati Therapeutics Inc Recent Developments/Updates
Table 125. Ono Pharmaceutical Co Ltd Corporation Information
Table 126. Ono Pharmaceutical Co Ltd Description and Business Overview
Table 127. Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Ono Pharmaceutical Co Ltd Tyrosine Protein Kinase Mer Product
Table 129. Ono Pharmaceutical Co Ltd Recent Developments/Updates
Table 130. Pfizer Inc Corporation Information
Table 131. Pfizer Inc Description and Business Overview
Table 132. Pfizer Inc Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Pfizer Inc Tyrosine Protein Kinase Mer Product
Table 134. Pfizer Inc Recent Developments/Updates
Table 135. Qurient Co Ltd Corporation Information
Table 136. Qurient Co Ltd Description and Business Overview
Table 137. Qurient Co Ltd Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Qurient Co Ltd Tyrosine Protein Kinase Mer Product
Table 139. Qurient Co Ltd Recent Developments/Updates
Table 140. Rgenix Inc Corporation Information
Table 141. Rgenix Inc Description and Business Overview
Table 142. Rgenix Inc Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Rgenix Inc Tyrosine Protein Kinase Mer Product
Table 144. Rgenix Inc Recent Developments/Updates
Table 145. SignalChem Lifesciences Corp Corporation Information
Table 146. SignalChem Lifesciences Corp Description and Business Overview
Table 147. SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. SignalChem Lifesciences Corp Tyrosine Protein Kinase Mer Product
Table 149. SignalChem Lifesciences Corp Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Tyrosine Protein Kinase Mer Distributors List
Table 153. Tyrosine Protein Kinase Mer Customers List
Table 154. Tyrosine Protein Kinase Mer Market Trends
Table 155. Tyrosine Protein Kinase Mer Market Drivers
Table 156. Tyrosine Protein Kinase Mer Market Challenges
Table 157. Tyrosine Protein Kinase Mer Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tyrosine Protein Kinase Mer
Figure 2. Global Tyrosine Protein Kinase Mer Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Tyrosine Protein Kinase Mer Market Share by Type in 2022 & 2029
Figure 4. Proto Oncogene c Mer Product Picture
Figure 5. Receptor Tyrosine Kinase MerTK Product Picture
Figure 6. MERTK Product Picture
Figure 7. EC 2.7.10.1 Product Picture
Figure 8. Global Tyrosine Protein Kinase Mer Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Tyrosine Protein Kinase Mer Market Share by Application in 2022 & 2029
Figure 10. Oncology
Figure 11. Ophthalmology
Figure 12. Global Tyrosine Protein Kinase Mer Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Tyrosine Protein Kinase Mer Market Size (2018-2029) & (US$ Million)
Figure 14. Global Tyrosine Protein Kinase Mer Sales (2018-2029) & (K Units)
Figure 15. Global Tyrosine Protein Kinase Mer Average Price (US$/Unit) & (2018-2029)
Figure 16. Tyrosine Protein Kinase Mer Report Years Considered
Figure 17. Tyrosine Protein Kinase Mer Sales Share by Manufacturers in 2022
Figure 18. Global Tyrosine Protein Kinase Mer Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Tyrosine Protein Kinase Mer Players: Market Share by Revenue in 2022
Figure 20. Tyrosine Protein Kinase Mer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Tyrosine Protein Kinase Mer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Tyrosine Protein Kinase Mer Sales Market Share by Country (2018-2029)
Figure 23. North America Tyrosine Protein Kinase Mer Revenue Market Share by Country (2018-2029)
Figure 24. United States Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Tyrosine Protein Kinase Mer Sales Market Share by Country (2018-2029)
Figure 27. Europe Tyrosine Protein Kinase Mer Revenue Market Share by Country (2018-2029)
Figure 28. Germany Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Tyrosine Protein Kinase Mer Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Tyrosine Protein Kinase Mer Revenue Market Share by Region (2018-2029)
Figure 35. China Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Tyrosine Protein Kinase Mer Sales Market Share by Country (2018-2029)
Figure 45. Latin America Tyrosine Protein Kinase Mer Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Tyrosine Protein Kinase Mer Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Tyrosine Protein Kinase Mer Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Tyrosine Protein Kinase Mer Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Tyrosine Protein Kinase Mer by Type (2018-2029)
Figure 55. Global Revenue Market Share of Tyrosine Protein Kinase Mer by Type (2018-2029)
Figure 56. Global Tyrosine Protein Kinase Mer Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Tyrosine Protein Kinase Mer by Application (2018-2029)
Figure 58. Global Revenue Market Share of Tyrosine Protein Kinase Mer by Application (2018-2029)
Figure 59. Global Tyrosine Protein Kinase Mer Price (US$/Unit) by Application (2018-2029)
Figure 60. Tyrosine Protein Kinase Mer Value Chain
Figure 61. Tyrosine Protein Kinase Mer Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 受容体チロシンプロテインキナーゼERBB 3のグローバル市場展望 2023年-2029年：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他
  • Rho関連プロテインキナーゼ2の世界市場2023年：AN-3485、KL-01045、AT-13148、TRX-101、その他
  • クレアチンキナーゼアッセイキットの世界市場2023年：酵素結合法、比色法
  • タンパク質濃縮器の世界市場2023年：1mL以下、1mL～5mL、5mL～20mL、20mL～100mL
  • 膜タンパク質抽出キットの世界市場2023年：哺乳類膜タンパク質、植物膜タンパク質
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8915 )"チロシンプロテインキナーゼマーの世界市場2023年：プロトオンコジーンc Mer、受容体チロシンキナーゼMerTK、MERTK、EC2.7.10.1" (英文：Global Tyrosine Protein Kinase Mer Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。